VIVS CIK: 1497253

VivoSim Labs, INC.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−8.45
FY23:
−12.4
FY24:
−14.7
FY25:
−9.46
FY26:
−10.8
Change from FY22 to FY26
millions USD
FY22:
−0.41
FY23:
−0.97
FY24:
0.82
FY25:
9.03
FY26:
0.09
Change from FY22 to FY26
millions USD
FY22:
0.21
FY23:
0
FY24:
1.44
FY25:
8.85
FY26:
4.45
millions USD
FY22:
−8.66
FY23:
−13.4
FY24:
−12.4
FY25:
8.41
FY26:
−6.29
(positive)
Change from FY22 to FY26
millions USD
FY22:
−8.86
FY23:
−12.8
FY24:
−14.7
FY25:
−9.47
FY26:
−10.8

All amounts in millions USD Data source:SEC EDGAR